In influenza vaccines, these proteins or peptides are primarily from the hemagglutinin (HA) and neuraminidase (NA) surface glycoproteins, which are critical for generating protective immune responses while eliminating potentially reactogenic viral components [94]. The gene discussed is XK; the disease is influenza.